Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: A methodological comparison
暂无分享,去创建一个
A. Blann | P. Goon | G. Lip | C. Boos | P. Stonelake
[1] A. Blann,et al. Circulating endothelial cells and endothelial progenitor cells: two sides of the same coin, or two different coins? , 2006, Atherosclerosis.
[2] E. Voest,et al. Phase I clinical evaluation of weekly administration of the novel vascular-targeting agent, ZD6126, in patients with solid tumors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] R. Jain,et al. Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] G. Doyle,et al. Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas. , 2006, Cancer research.
[5] E. Mohler,et al. Flow cytometric measurement of circulating endothelial cells: The effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations , 2006, Cytometry. Part B, Clinical cytometry.
[6] D. Stupack,et al. A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. , 2006, The Journal of clinical investigation.
[7] F Dignat-George,et al. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry , 2006, Cytometry. Part B, Clinical cytometry.
[8] M. Haubitz,et al. Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol , 2006, Journal of thrombosis and haemostasis : JTH.
[9] G. Lip,et al. Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. , 2006, Neoplasia.
[10] B. Thürlimann,et al. Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer , 2006, British Journal of Cancer.
[11] C. Gentile,et al. Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells , 2005, Thrombosis and Haemostasis.
[12] Ricky T. Tong,et al. Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] J. P. McCoy,et al. CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. , 2005, Blood.
[14] M. Haubitz,et al. Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA associated vasculitis , 2005, Annals of the rheumatic diseases.
[15] G. Nickenig,et al. Circulating endothelial progenitor cells and cardiovascular outcomes. , 2005, The New England journal of medicine.
[16] C. Ponticelli,et al. Increased levels of circulating endothelial cells in chronic periaortitis as a marker of active disease. , 2005, Kidney international.
[17] Hong Zhang,et al. Circulating endothelial progenitor cells in multiple myeloma: implications and significance. , 2005, Blood.
[18] G. Lip,et al. Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. , 2005, Blood.
[19] Françoise Dignat-George,et al. Circulating endothelial cells , 2005, Thrombosis and Haemostasis.
[20] E. Voest,et al. Circulating endothelial cells in cancer patients do not express tissue factor. , 2004, Cancer letters.
[21] M. Haubitz,et al. An improved assay for enumeration of circulating endothelial cells , 2004, Annals of Hematology.
[22] R. Brook,et al. Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity. , 2004, Blood.
[23] F. Ingegnoli,et al. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. , 2004, Arthritis and rheumatism.
[24] G. Lip,et al. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor. , 2004, European heart journal.
[25] Ricky T. Tong,et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.
[26] K. Nakatani,et al. Circulating Endothelial Cells in Kawasaki Disease , 2003, Clinical and experimental immunology.
[27] M. Haubitz,et al. Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis , 2003, The Lancet.
[28] C. Verfaillie,et al. Origin of endothelial progenitors in human postnatal bone marrow. , 2002, The Journal of clinical investigation.
[29] A. Goldhirsch,et al. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. , 2001, Blood.
[30] B. Chabrol,et al. Circulating Endothelial Cells in Behçet’ Disease with Cerebral Thrombophlebitis , 2000, Thrombosis and Haemostasis.
[31] Robert P. Hebbel,et al. Sickle Cell Anemia as a Possible State of Enhanced Anti-Apoptotic Tone: Survival Effect of Vascular Endothelial Growth Factor on Circulating and Unanchored Endothelial Cells , 1999 .
[32] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.
[33] D. Raoult,et al. Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever [see comments] , 1993 .
[34] J. Sampol,et al. Detection of Circulating Endothelial Cells in Thrombotic Thrombocytopenic Purpura , 1993, Thrombosis and Haemostasis.
[35] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[36] G. Lip,et al. Circulating endothelial cells: markers of vascular dysfunction. , 2005, Clinical laboratory.
[37] E. Voest,et al. Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[38] A. Blann,et al. HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Direct Evidence of Endothelial Injury in Acute Myocardial Infarction and Unstable Angina by Demonstration of Circulating Endothelial Cells , 1999 .
[39] R. Hebbel,et al. Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells. , 1999, Blood.